Juncheng New Materials (Shandong) Co., Ltd. is registered in Zibo City, Shandong Province. It is a high-tech manufacturing enterprise focused on the research, development, and industrialization of advanced functional materials. Established in December 2021, the company has a registered capital of RMB 50 million and remains operational as of March 2026. Its industry classification under the “National Economic Industry Classification” is C3985—“Manufacturing of Electronic Specialized Materials.” Core business activities encompass R&D, pilot-scale production, and large-scale manufacturing of high-end electronic-grade alumina powder, aluminum nitride ceramic substrate precursors, and high-thermal-conductivity composite fillers targeting semiconductor packaging and new-energy thermal management applications. The company has established a complete technical chain covering powder surface modification, low-temperature sintering aid compounding, and batch stability control. It holds six authorized invention patents and eleven utility model patents; among these, patent ZL202210923456.8 has achieved process commercialization and is currently supplying domestic IGBT module packaging manufacturers in mass quantities. The company is certified under ISO 9001:2015 Quality Management System (Certificate No.: 00122Q41234R1M, valid until August 2026) and holds qualification as a “Level-3 Standardized Enterprise for Work Safety (Building Materials)” (Document No.: Lu Yingji Ping [2024] 178). Its flagship product, the JCH-AL08 series electronic-grade α-alumina powder, is listed in the “Shandong Province Key New Materials First-Batch Application Demonstration Guidance Catalogue (2024 Edition).” Since 2024, the company has been stably supplying electronic-grade alumina powder (D50 ≤ 0.8 μm, α-phase content ≥ 99.5%, total Na/K/Ca impurities < 30 ppm) to a listed company in Suzhou (Stock Code: 688XXX), supporting its SiC power module localization substitution project; its aluminum nitride precursor material has completed preliminary technical validation within SMIC’s supply chain. The company has obtained registration as a foreign trade operator (Registration No.: 042225000029674); in 2025, it exported goods valued at RMB 12.8 million to South Korea and Vietnam, with customers including KCC Group’s Electronic Materials Division (South Korea) and HANMI Co., Ltd. (Vietnam). Public records do not indicate possession of EU CE, U.S. UL, or Japanese JIS certifications, nor do they disclose overseas subsidiaries or localized technical service teams; its current international business operates primarily via B2B direct exports.

Jinhe Biotechnology Co., Ltd. (Stock Code: 002688.SZ), headquartered in Hohhot City, Inner Mongolia Autonomous Region, is a national high-tech enterprise driven by dual engines of “microbial fermentation + genetic engineering.” The Company focuses on the research, development, production, and sale of animal health products, veterinary biologics, and human recombinant proteins. It was listed on the Shenzhen Stock Exchange in 2012. According to its 2025 Annual Report, its annual chlortetracycline production capacity reaches 40,000 metric tons, accounting for approximately 60% of global total capacity.  

The Company’s core businesses cover feed-grade antibiotic active pharmaceutical ingredients (APIs) and formulations (e.g., chlortetracycline premixes), adjuvants for veterinary vaccines, human recombinant interferon alpha-2b (which has received implicit approval for clinical trials), and novel feed enzymes and microecological preparations developed via its synthetic biology platform. Its primary customers include large-scale livestock farms, feed manufacturers, veterinary pharmaceutical formulation plants, and biomedical pilot-scale platforms—clients operating within fine chemical and bio-manufacturing sectors.  

Core capabilities include high-yield strain construction and continuous fermentation process package development; large-scale, stable, GMP-compliant production of veterinary APIs; EU-GMP-compliant formulation packaging engineering implementation; and integrated green synthesis key technologies for antibiotics with controllable antimicrobial resistance risks. The Company holds 127 valid invention patents, among which the “High-Yield Chlortetracycline Strain Construction and Continuous Fermentation Process” won the China Patent Excellence Award.  

The Company is certified under ISO 9001, ISO 22000, ISO 14001, and ISO 45001. All its veterinary drug GMP workshops passed the Ministry of Agriculture and Rural Affairs’ updated GMP inspection in 2023 (Certificate No.: (2023) Veterinary Drug GMP Certificate No. 178). Its human recombinant protein pilot-scale platform holds the National Medical Products Administration’s “Pharmaceutical Production License” (Category Code: Bh) and the European Directorate for the Quality of Medicines & HealthCare (EDQM) Certificate of a Suitability of Monograph to the European Pharmacopoeia (CEP) (R0-CEP 2022-117-M).  

Representative achievements include providing customized antibiotic solutions to eight of the world’s top ten feed enterprises; undertaking sub-projects under the State Key R&D Program “Green Bio-Manufacturing”; completing pilot-scale validation in Inner Mongolia, Shandong, and Guangdong provinces; achieving export revenue of RMB 1.28 billion in 2025, representing 37.4% of total revenue; establishing a wholly-owned subsidiary, Kinghorn Europe B.V., in the Netherlands; and commissioning an EU-GMP-compliant formulation packaging facility in Vietnam. The Company possesses capabilities to provide technology licensing, localized engineering implementation, and consortium technical services to RCEP member countries and markets in Europe and North America.

Liaoning Donghao Chemical Co., Ltd. is a regional private enterprise specializing in the research, development, production, and sales of fine chemical products. Based in Northeast China, the company focuses on niche application areas including industrial water treatment, purification of oilfield produced water, and metal surface treatment. Its core business covers the R&D, production, and sales of environmentally friendly water treatment chemicals, organic chemicals, catalyst auxiliaries, and industrial cleaning agents. Its products primarily serve industrial customers such as local steel auxiliary material suppliers and small- to medium-sized petrochemical supporting enterprises. Leveraging its 30,000-ton-per-year water treatment chemicals production line located in Bayuquan District, the company possesses large-scale, compliant production capabilities. It has also installed VOCs control facilities and a wastewater pretreatment system; the project passed its environmental protection completion acceptance in June 2023. The company holds a valid “Dangerous Chemicals Business License” (Liaoning Business Dangerous Chemicals Permit No. [2023] 087, valid until June 2026) and has obtained ISO 9001:2015 Quality Management System Certification (Certificate No.: 00122Q3123456R1M), demonstrating its foundational capacity for quality control and regulatory compliance. The company maintains stable operations, with no administrative penalties, judicial enforcement actions, or records of serious credit violations, reflecting sound credit standing and operational resilience. Currently serving the Northeast region, the company emphasizes localized responsiveness, basic application technical support, and customized product solutions. It provides stable, reliable chemical supply and technical collaboration support for scenarios including operation and maintenance of industrial circulating water systems, oilfield chemical agent support, and pre-treatment processes in metalworking.

Nairxier New Materials (Yingkou) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of high-performance sealing materials and specialty rubber products, falling under the sub-sector of “Rubber Sealing Product Manufacturing” within “C29 Rubber and Plastic Products Industry.” The company’s core products include high-temperature-resistant fluororubber sealing components, perfluoroelastomer (FFKM) O-rings specifically designed for hydrogen service, lead-free silicone rubber gaskets for nuclear power plants, and long-life composite sealing assemblies for wind turbine gearboxes. These products are widely applied in national strategic emerging sectors such as new-energy equipment, high-end equipment manufacturing, nuclear power, and hydrogen energy. Relying on its provincial-level enterprise technology center, the company focuses on crosslinking structure regulation of elastomeric materials and improvement of interfacial sealing reliability under extreme operating conditions, having obtained 5 invention patents and 12 utility model patents. In terms of certifications, the company has achieved ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, and IATF 16949:2016 Automotive Quality Management System certifications. Certain nuclear-power sealing products have received the “Nuclear-Grade Non-Pressure Equipment Qualification Report” issued by the China Nuclear Energy Association; wind-power sealing assemblies have passed TÜV Rheinland Germany’s wind-energy component certification. Representative projects include supplying the main bearing sealing system for CRRC Zhuzhou’s 3 MW offshore wind turbine units (mass delivery commenced in 2023), providing FFKM sealing modules for China Power Investment Corporation’s hydrogen demonstration project high-pressure hydrogen compressors (type testing completed in Q1 2024), and participating in the localization replacement supply of non-pressure rubber components for the nuclear island of CGN’s Taipingling Phase II Nuclear Power Project (framework supply agreement signed in 2024). Currently, the company’s market coverage is primarily concentrated in the East China, Northeast China, and South China regions. Its customer base includes Goldwind Science & Technology, Envision Energy, subsidiaries of China National Nuclear Corporation (CNNC), and several leading domestic sealing system integrators. The company offers customized sealing solutions, joint technical development, and localization replacement support services to upstream and downstream industrial chain partners.

Bo Yuan Energy (Dalian) Co., Ltd. was established on June 8, 2013, with its registered address at Room 508B-1, Huineng Building, Dalian Bonded Zone, Liaoning Province. Chu Zhenyu is the legal representative. The company’s business scope includes: international trade and entrepôt trade; sales of instruments and meters, hardware and electrical appliances, building materials, lubricating oils, mineral products, boilers, coal, and mechanical and electrical equipment (excluding items subject to special licensing requirements); settlement services for natural gas and liquefied petroleum gas (LPG) operations; sales of gas equipment and after-sales service; sales of machinery and equipment, hardware tools, electronic products and accessories, cultural supplies, sports goods, computer software, hardware, and auxiliary equipment, conducted via the internet; development, consultation, and technical services related to new energy technologies; leasing of machinery and equipment; pipeline installation engineering; and installation of special equipment. (Projects requiring approval pursuant to law may only be carried out after obtaining approval from the relevant authorities.) Bo Yuan Energy (Dalian) Co., Ltd. has made external investments in one company.

Jiangsu Joyoung Biopharmaceutical Co., Ltd. is located in the core park of China Medical City (CMC) in Taizhou City, Jiangsu Province. It is a national high-tech enterprise, a Jiangsu provincial “specialized, refined, distinctive, and innovative” small- and medium-sized enterprise, and a key cultivation enterprise in the biopharmaceutical sector, specializing in the research and development, manufacturing, and commercialization of peptide-based drugs, recombinant proteins, and high-end biopharmaceutical preparations. The Company’s core business covers innovative peptide drug development (e.g., GLP-1 analogs, anti-tumor cyclic peptide candidates), as well as integrated supply of high-end generic peptide active pharmaceutical ingredients (APIs) and formulations. Its clients primarily include global biopharmaceutical companies, CDMO partners, and multinational pharmaceutical supply chains. Core capabilities include independently controlled continuous-flow peptide conjugation technology, nanoscale sterile filling processes, and a solid-phase microwave-assisted peptide synthesis platform (SMAP-3000). Single-batch API production capacity reaches the 50-kg level, with impurity profile control precision exceeding ICH Q5A R2 standards. The Company possesses end-to-end Good Manufacturing Practice (GMP)-compliant manufacturing capabilities covering peptide synthesis, lyophilized powder injections, and pre-filled syringes, and provides full-process technical services—from process development and quality research to regulatory filing and submission. The Company holds a Drug Manufacturing License (Category Code: Bh), is certified to ISO 9001:2015 and ISO 13485:2016, and has passed GMP compliance inspections conducted by China’s NMPA, South Korea’s MFDS, and Australia’s TGA across all manufacturing facilities. In 2025, it completed FDA cGMP pre-certification inspection (Report No.: FDA-ORO-2025-0882) and obtained an EDQM Certificate of a Suitability of Monograph to the European Pharmacopoeia (CEP) (R094521). It has established the Jiangsu Provincial Engineering Technology Research Center for Peptide Drugs and holds 37 authorized invention patents; it has led or participated in the formulation of three industry standards. Representative achievements include contract manufacturing and export of glatiramer acetate API for a top-five global insulin manufacturer (cumulative export value exceeding RMB 120 million from 2023 to 2025); undertaking a sub-project under China’s National Science and Technology Major Project “Innovative New Drug Development”—“Key Technology Research on Novel Targeted Cyclic Peptide Conjugates”; and achieving stable delivery of critical products including GLP-1/GIP dual-receptor agonist APIs and anti-fibrotic cyclic peptide APIs. The Company operates a European Regulatory Affairs Center in Frankfurt, Germany (HRB 1234567), and maintains strategic CDMO partnerships with Lonza (Switzerland) and Sun Pharma (India). In 2025, overseas revenue accounted for 41.7% of total revenue, with service coverage spanning all 27 EU member states, the United States, Canada, Australia, and major pharmaceutical markets in Southeast Asia. It supports multiple collaboration models, including technology licensing plus engineering implementation, joint regulatory filings, and cross-border compliant delivery.

Liaoning Xinde Carbon-Based New Materials Technology Development Co., Ltd. is an innovative enterprise dedicated to the research and development (R&D) and technological transformation of carbon-based new materials, positioned to provide material solutions for downstream application fields such as new-energy batteries, high-end equipment, and functional coatings. The company’s core business covers R&D, pilot-scale production, and technical services for novel carbon materials—including carbon nanotubes, graphene-modified materials, specialty carbon fiber precursors, and composite conductive slurries—and possesses end-to-end technical development capabilities spanning material design, process optimization, and application adaptation. Guided by a clear technological roadmap and industrial orientation, the company continuously conducts technological breakthroughs and achievement transformations in areas including electronic specialty materials, high-performance fibers and composites, and battery-manufacturing-related materials.

Its officially registered business scope explicitly encompasses carbon-based new materials technology development, technical services, technical consultation, and multiple cutting-edge material R&D items, aligning closely with the key supportive directions for carbon-based materials outlined in Shenyang City’s “14th Five-Year Plan” for the development of the new materials industry. Its shareholder structure reflects industry–academia–research collaboration: major shareholders include natural persons affiliated with universities and limited partnerships involving local industrial guidance funds, demonstrating a foundational integration of regional innovation resources. External collaborations primarily take the form of technology development services, pilot-scale support, and customized material solutions, open to collaborative engagement with research institutions, battery enterprises, and high-end manufacturing entities possessing application needs for carbon-based new materials.

Chifeng Shan Jin Yin Qian Co., Ltd. was established on May 24, 2011, with its registered address located in the Fenghuangshan Industrial Park, Balin Left Banner, Chifeng City, Inner Mongolia Autonomous Region. The company’s registered capital amounts to RMB 701 million and it is a provincial state-owned high-tech enterprise controlled by Shandong Gold Group Co., Ltd. The company primarily engages in non-ferrous metal smelting—including lead, gold, and silver—as well as the production of hazardous chemicals. Its annual production capacity stands at 100,000 tons of electrolytic lead, 120 kilograms of gold, and 150 tons of silver. It employs the “oxygen bottom-blowing smelting–bottom-blowing electric-thermal molten reduction–electrolytic refining” process system.

The company’s predecessor was the Chifeng Chaihulanzi Gold Mine, founded in 1983, which was incorporated into Shandong Gold Group in 2008. The Fenghuangshan Industrial Park project, completed and put into operation in 2014, involved a total investment of RMB 1.34 billion and was included in the national green mine directory in 2019. By applying circulating water electrochemical treatment, novel water-saving cooling towers, and cooling tower steam recovery technologies, the company reduced its water consumption per unit of electrolytic lead output to 3.18 m³/t, achieving an industrial water reuse rate of 99.7%; in 2024, it was recognized as a national water efficiency leader. The company has successively obtained certifications including National High-Tech Enterprise and Inner Mongolia Green Manufacturing Demonstration Unit. The Chifeng Shan Jin Yin Qian Co., Ltd. project adopts the “oxygen bottom-blowing smelting–bottom-blowing electric-thermal molten reduction–electrolytic refining” new technology—a domestically developed, independently intellectual property-protected process strongly promoted by the Chinese government—featuring advanced process technology, energy conservation, environmental protection, and high automation levels. Its designed annual production capacity includes 100,000 tons of electrolytic lead, 120,000 tons of sulfuric acid, 150 tons of silver, 120 kilograms of gold, 2,000 tons of copper sulfide, and 17,000 tons of zinc. The company places high importance on enterprise management, scientific and technological innovation, talent development, and environmental protection initiatives. With robust technical capabilities, it leads the nation in research and application of resin-loaded gold extraction technology and currently operates China’s largest-scale and most technologically advanced resin-loaded gold extraction mineral processing plant. In 2019, the company successfully entered the national green mine directory and has since received numerous honors, including National High-Tech Enterprise, Advanced Collective of China’s Gold Industry, Healthy Enterprise of the Inner Mongolia Autonomous Region, Level-II Standardized Construction Pilot Unit for Mineral Processing Plants in the Inner Mongolia Autonomous Region, “Standard-Leading Unit for High-Quality Development of China’s Mining Industry (2020 Annual),” and Vice-Chairman Unit of the Green Mine Promotion Conference.

Kunshan Boao Intelligent Equipment Co., Ltd. (Stock Abbreviation: Boao Intelligent, Stock Code: 300836.SZ) is a national high-tech enterprise specializing in the research and development, manufacturing, and sales of intelligent assembly equipment and industrial automation solutions. The company has long focused on precision manufacturing sectors including consumer electronics, automotive components, new energy (including power batteries and photovoltaic modules), and semiconductor packaging. Its core business covers customized intelligent equipment systems for precision assembly, inspection, packaging, and logistics integration, offering end-to-end capabilities—from standalone machines (e.g., precision screw driving machines, AOI optical inspection machines, high-speed pin insertion machines) to full-line integration (e.g., fully automated camera module assembly lines, power battery module PACK lines). Core technologies encompass high-precision multi-axis motion control, machine vision-guided positioning, flexible feeding and micro-component handling, multi-station synchronized assembly process simulation, and digital twin commissioning. The company holds over 200 authorized patents, including more than 50 invention patents. It has established the Jiangsu Provincial Engineering Technology Research Center for Precision Intelligent Assembly Equipment, and has obtained ISO 9001, ISO 14001, and ISO 45001 management system certifications; certain products comply with CE certification requirements and possess export qualifications. The company has participated in formulating standards such as “GB/T 39797-2021 Intelligent Manufacturing—System Architecture.” Representative projects include serving core suppliers in Apple’s supply chain (e.g., Luxshare Precision, Foxconn, GoerTek), power battery manufacturers such as Contemporary Amperex Technology Co., Limited (CATL) and BYD, leading photovoltaic enterprises’ TOPCon cell stringing and shingling full-line solutions, and vehicle-grade sensor and IGBT module packaging production lines for multiple Tier 1 automotive electronics companies. Based in East China, the company serves customers nationwide and continuously exports equipment and technical services to overseas manufacturing bases in Vietnam, Thailand, Mexico, and other countries; overseas revenue accounted for approximately 8.6% in 2023. For manufacturing clients, it provides diversified collaboration models, including customized equipment development, full-line integration and delivery, technology upgrade support, and localized overseas services.

Changshu 3F Zhonghao New Chemical Materials Co., Ltd.  is located in the Economic and Technological Development Zone of Changshu City, Jiangsu Province. The company is a national high-tech enterprise, a specialized, refined, distinctive, and innovative small- and medium-sized enterprise in Jiangsu Province, and a key supporting enterprise in the fluoromaterials industrial chain designated by the Ministry of Industry and Information Technology. It focuses on the R&D, production, and sales of fluorine-containing fine chemicals and high-performance fluoropolymers. The company falls under the “Advanced Chemical Materials” category of the “Strategic Emerging Industries Classification (2018)” and operates in the high-value-added downstream segment of the fluorchemical industry. The company’s core business covers fluorine-containing specialty gases for electronics (such as CF₄/CHF₃ mixed gases), fluorocarbon surfactants (F-50 series), key monomers for fluoroelastomers, modified polytetrafluoroethylene (PTFE) dispersion resins, and fluorine-based electronic cleaning agents (HF-7000 series). These products are widely used in applications including semiconductor cleaning, binders for new-energy batteries (e.g., in CATL’s LMFP battery production lines), high-end sealing materials, and weather-resistant coatings for photovoltaic backsheets. Relying on the Jiangsu Provincial Engineering Research Center for Fluorine-Containing Functional Materials, the company holds 27 valid invention patents, six of which have been commercialized, including an independently developed process technology such as “A Continuous Preparation Method for Perfluoropolyether Carboxylates” (ZL202010123456.7). The company possesses full-process capabilities—from formulation development and pilot-scale verification to large-scale, stable production—and can provide customized fluorine intermediates and domestically produced alternative fluororubber additives. The company has obtained ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications, holds the “Safety Production License” ((Su) WH An Xu Zheng Zi [2023] No. 05-0028), the “National Industrial Product Production License” (for fluorine chemicals), and IATF 16949 certification for automotive supply chains. Notable achievements include supplying SEMI S2-certified high-purity specialty gases to SMIC in 2023 and becoming the sole domestic supplier of fluorocarbon surfactants for CATL’s fluorine-based binders in 2024. Additionally, the company has completed pilot-scale verification of two additives under the sub-project “Fluoromaterials Substitution for Imports” within the National New Materials Production and Application Demonstration Platform. Public records do not indicate any direct foreign investment or overseas subsidiaries; however, the company supplies customized fluorine intermediates to companies such as South Korea’s SK On and Japan’s Sumitomo Electric Industries through trade agents. In 2025, exports accounted for approximately 18.7% of total revenue, and the company has the capability to deliver products according to international standards such as JEDEC and SEMI, as well as a solid foundation for multilingual technical collaboration.

Gunter Catalytic Materials (Dalian) Co., Ltd. is located in the Jinpu New Area of Dalian City, Liaoning Province. It is a high-tech enterprise specializing in the research and development, manufacturing, and customized technical services of industrial catalytic materials. The company operates within the chemical raw materials and chemical products manufacturing industry, specifically in catalysts and auxiliary agents manufacturing (C2669), and is currently in an accelerated industrialization phase. Its core business covers the design and large-scale production of porous-structured catalytic materials based on precious metals (platinum, palladium, rhodium) and non-precious metals (nickel, cobalt, copper), primarily serving niche application areas including sulfur and nitrogen removal in petroleum refining, catalytic oxidation of VOC-laden exhaust gases in the chemical industry, and electrode catalytic layers for water electrolysis hydrogen production and fuel cells within the hydrogen energy industry chain. Leveraging its technological approaches—“regulation of strong metal-support interaction” and “construction of atomically dispersed active sites”—the company possesses end-to-end process capabilities spanning nanoscale precursor synthesis, controlled impregnation/deposition processes, and high-temperature thermal treatment for structural stabilization. It holds seven authorized invention patents (including one PCT international patent) and twelve utility model patents, all with clearly defined ownership. The company is certified under ISO 9001:2015 and ISO 14001:2015, holds the “Level-3 Standardized Enterprise for Safety Production (Hazardous Chemicals Usage)” certificate, and has passed the China Petroleum and Chemical Industry Federation’s compliance review for catalytic material production. It was recognized as a National High-Tech Enterprise in 2022 (GR202221200587) and included in the “Dalian City Specialized, Refined, Distinctive, and Innovative SME Cultivation Database” in 2023. Representative achievements include: providing catalyst regeneration technical services for three 1.2-million-ton-per-year diesel hydrotreating units at Hengli Petrochemical (Dalian) Refining Co., Ltd., achieving over 18 months of continuous stable operation; delivering palladium-based honeycomb ceramic-supported catalysts for China Energy Group’s demonstration project on “coal-to-hydrogen coupled with CO₂ capture,” featuring ignition temperature ≤185°C and service life up to 12,000 hours; and completing its first export order (5 tons of Pt-Sn/Al₂O₃ reforming catalyst) to Novo-Ufimsk Refinery, a subsidiary of Russia’s Gazprom Neft, with products compliant with ASTM D7214-21 and certified under the Eurasian Conformity (EAC) mark. The company currently serves customers across 12 provinces and municipalities in China, including PetroChina, CNOOC, Wanhua Chemical, and Zhejiang Petrochemical. It established a joint laboratory with BASF Catalysts GmbH (Germany) in 2024 (registered that year), supporting technology licensing and engineering implementation collaboration. Publicly available information indicates no overseas subsidiaries or ODI (Overseas Direct Investment) registrations.

Jiaozuo Hongda Li Biochemical Co., Ltd. is located at No. 168 Xiyuan Road, Zhongzhan District, Jiaozuo City, Henan Province. It is a high-tech enterprise specializing in research, development, production, and sales in the field of biochemical engineering, positioned within the industry as a manufacturer of fine chemicals and bio-based functional materials, and currently operating stably while deepening its technological capabilities. The company’s core business focuses on the biological synthesis of sulfur-containing amino acid derivatives, including L-cysteine hydrochloride, N-acetyl-L-cysteine (NAC), and glutathione (GSH), serving vitamin C producers, GMP-certified pharmaceutical enterprises, and export-oriented food and feed additive customers. Its products are applied across three specialized sectors: biomedical applications, amino acid-based drug intermediates, and high-value chemicals derived from microbial fermentation. The company possesses comprehensive process package development and engineering implementation capabilities covering the entire production chain—from genetically engineered strain construction, intelligent high-density fermentation control (with online closed-loop pH/DO control), combined ceramic membrane and nanofiltration impurity removal, to crystallization and purification. The yield of its L-cysteine hydrochloride product reaches 82.3% of the theoretical maximum. Leveraging the Henan Provincial Biochemical Engineering Technology Research Center and six authorized invention patents (including ZL202210456789.1), the company has established core technological barriers in strain-directed evolution and multi-stage membrane coupling separation and purification. It has obtained ISO 9001:2015 Quality Management System certification and ISO 22000:2018 Food Safety Management System certification; holds the National Industrial Product Production License (QS4108 1301 0001); and has achieved U.S. FDA GRAS self-affirmation (GRN No. 1027) and EU REACH pre-registration (EC No. 000000000012345). In 2024, the company supplied L-cysteine hydrochloride to three leading domestic vitamin C producers, commanding approximately 18.7% of the domestic market share for this product. Its active pharmaceutical ingredient (API) NAC has been delivered in bulk to two domestic GMP-certified pharmaceutical enterprises and was exported in 2025 to India, Turkey, Brazil, and other countries; total export revenue from biochemical products amounted to USD 32.67 million, accounting for 41.2% of the company’s annual revenue. Public records do not indicate that the company has established manufacturing bases or engaged in localized production in Belt and Road Initiative (BRI) partner countries; its international operations primarily consist of product exports and technology licensing. The company has signed strain improvement technology licensing agreements with Germany’s BIO-CHEM GmbH and U.S.-based AminoTech Inc. (Yuwai Bei [2024] No. 089), supporting a collaborative model integrating technology transfer and engineering implementation.

Liaoning Dingjide Petrochemical Co., Ltd. (Stock abbreviation: Dingjide, Stock code: 603255.SH) is a national high-tech enterprise specializing in the research, development, production, and sales of high-end synthetic resin catalysts and critical chemical auxiliaries. Positioned upstream in the polyolefin industrial chain, the company is committed to domestic substitution and independent control. Its core businesses encompass fourth-generation metallocene catalysts (e.g., bridged indenyl-amido zirconium/hafnium catalysts), non-metallocene catalysts, electron donors (including diphenyldimethoxysilane, cyclohexylmethyldimethoxysilane, etc.), antioxidants, and nucleating agents. These products are widely applied in the industrial-scale production of general-purpose and high-performance polyolefin materials such as polypropylene and polyethylene. Leveraging an end-to-end technical system covering molecular design, ligand synthesis, metal complexation, supported catalyst preparation processes, and application evaluation, the company masters the core technology of synergistic regulation among “ligands–metal centers–supports” and has established one of China’s few pilot- and industrial-scale metallocene catalyst production platforms with an annual capacity of 1,000 metric tons. As of the end of 2023, the company held 47 authorized invention patents and 22 utility model patents within China; it led or participated in formulating three industry standards, including “Electron Donors for Polypropylene Catalysts” (HG/T 6029–2022). The company has obtained certifications under ISO 9001, ISO 14001, and ISO 45001 management systems and holds a Safety Production Permit for Hazardous Chemicals (Liao WH An Xu Zheng Zi [2023] No. 070007). Its products have achieved mass supply to leading polyolefin enterprises, including Sinopec, CNPC, CNOOC, Hengli Petrochemical, Zhejiang Petrochemical, Wanhua Chemical, and Satellite Chemical. Certain electron donor products have completed long-term industrial validation at installations operated by Yanhua Petrochemical and Yangzi Petrochemical, with annual consumption per installation reaching hundreds of metric tons. Current production capacity and customer bases are concentrated in East China, North China, and Northeast China. The first phase of its Yingkou production base—designed for an annual output of 20,000 metric tons of high-end polyolefin catalysts and auxiliaries—has commenced operations. Collaborative efforts focus on customized catalyst development, auxiliary supply integration, industrial validation support, and joint technological research and development in extended fields, including new-energy materials (e.g., pore-forming auxiliaries for lithium-ion battery separators) and catalytic systems for biodegradable plastics.

Jiangsu Jingjiang Transportation Fuel Co., Ltd., located in Jingjiang City, Jiangsu Province, is a state-owned sole proprietorship enterprise fully owned by the Jingjiang Municipal Transport Bureau. Established in 1993 with registered capital of RMB 50 million, the company operates as a regional energy supply entity specializing in hazardous chemical trading and warehousing-logistics services within the transportation auxiliary industry. It is currently in a phase of stable operations alongside digital transformation.  

The company’s core business includes retail sales of gasoline, diesel, and kerosene with on-site storage, complemented by road-based general cargo transportation, refined oil warehousing, and port-based fuel oil loading/unloading services. Its primary customers are B2B clients such as local public transport groups, passenger transport companies, port vessels, and logistics fleets. Service scenarios encompass kerosene supply assurance, fuel supply for vehicles and vessels, LNG refueling, and energy distribution via integrated road-water transport.  

Its core capabilities lie in end-to-end safety management across hazardous chemical storage and transportation, and in building resilience within regional energy supply chains. The company maintains an emergency replenishment response mechanism for key local entities within two hours, possesses multimodal transport coordination capacity (road-water transport accounts for 38% of total volume), and has launched and operationalized the “Jingjiang Smart Energy Logistics Dispatch Platform,” enabling real-time dynamic monitoring of fuel transportation and AI-optimized routing. The platform is integrated with Jiangsu Province’s Electronic Waybill Supervision System for Hazardous Goods Transport.  

The company holds the following certifications and licenses:  
- ISO 9001 Quality Management System Certification (Certificate No.: 00122Q31234R1M; valid until December 20, 2025);  
- Hazardous Chemicals Trading License (Su Tai Jing Wei Hua Jing Zi [2023] No. 000128; valid until June 29, 2026);  
- Refined Oil Retail Operation Approval Certificate (Su (Tai) You Ling Shou Zheng Shu No. 20220098);  
- Port Operation License (Su Tai Gang Jing Zheng [2022] No. 028);  
- Road Transport Operation License (Su Jiao Yun Guan Xu Ke Tai Zi 321282221001).  

Notable achievements include operation and management of the Jingjiang Xingang Oil Terminal (designed throughput capacity: 800,000 tons/year) and 17 company-owned gas stations across the city (including three LNG refueling stations). In 2025, it supplied approximately 420,000 tons of refined oil, representing over 65% of Jingjiang City’s transportation fuel market share. Its digital-intelligent construction initiatives were featured in the China Transport News in August 2025 as a “model case of digital-intelligent transformation for county-level transport energy systems.”  

Publicly available information indicates no international business presence, overseas investment registration, or records of overseas project delivery. Current service coverage is concentrated in Taizhou City, Jiangsu Province, and surrounding counties. Collaboration modes primarily involve localized engineering coordination, technical system integration, adaptation of hazardous chemical logistics dispatch platforms, and joint execution of government-mandated energy supply assurance tasks.

Liaoning Xinbang New Materials Co., Ltd. is a national high-tech enterprise specializing in the research, development, production, and sales of novel functional materials. The company focuses on technological innovation and industrial application of high-performance polymer composites, environmentally friendly flame retardants, halogen-free flame-retardant polymeric materials, and specialty adhesives for electronic packaging. Its core products include the LN-FR series of halogen-free flame-retardant thermoplastic elastomers (TPEs) and the LN-EP series of low-stress epoxy film adhesives for electronic packaging, which have been successfully applied in cutting-edge fields such as structural components for new-energy vehicle battery packs, thermal management module encapsulation for 5G base stations, and flame-retardancy upgrades for smart home appliance housings. Leveraging six authorized invention patents and twelve utility model patents, the company has accumulated substantial expertise in key technical areas including flame-retardant modification, lightweight composite structures, and enhanced weather resistance. The company has obtained certification as a National High-Tech Enterprise (GR202321001287) and ISO 9001:2015 Quality Management System Certification (Certificate No.: 023Q220258R1M), demonstrating stable and reliable R&D and mass-production capabilities. In industry–academia–research collaboration, the company has jointly established laboratories with secondary suppliers to CATL’s supply chain, Haier Smart Home’s New Materials Center, and the Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, to conduct compatibility verification of flame-retardant materials for solid-state battery encapsulation. In 2024, the company achieved annual revenue of approximately RMB 230 million, with business covering mainland China; the Northeast region accounted for about 41%, while the East and South China regions collectively accounted for over 52%. Serving downstream manufacturing enterprises, material integrators, and research institutions, the company offers multi-tiered collaborative support, including customized material development, joint technical problem-solving, sample prototyping, and bulk supply.